Clinical Trials Directory

Trials / Completed

CompletedNCT03150433

Sleep and Pain in Sickle Cell Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.

Detailed description

The investigators propose to examine whether changes in sleep alter pain and pain-related outcomes in adults with Sickle Cell Disease (SCD). As many as 70% of adults with SCD experience various sleep disturbances. Pain and sleep are inter-related, such that pain disturbs sleep and disturbed sleep amplifies pain and increases risk for developing chronic pain. Pain processing occurs in the central nervous system, where nociceptive input can be inhibited or facilitated and which can undergo both functional and structural plasticity. When plasticity results in amplification of pain, this central sensitization (CS) manifests as hyperalgesia, allodynia, and spreading of pain and is an important treatment target in its own right. A growing literature implicates central sensitization in SCD, and the investigators find a strong association between laboratory-evoked CS and sleep disturbance in SCD. The neural substrates involved in pain modulation are often disrupted in chronic pain, likely due to the demands pain places on cognitive resources, and similar effects are seen with chronic insomnia. It remains unclear whether these changes occur in SCD and if improving sleep improves central modulation of pain. The potential for improved sleep to reduce pain and CS requires additional investigation, particularly given the significance of sleep disturbance as a mutable risk factor. The investigators will conduct a randomized trial in which it will be determined whether improvements in sleep reduce pain and alter brain processing of pain and cognitive stimuli. The aims are to determine whether treatment of sleep improves pain outcomes in SCD and to determine whether treatment of sleep alters functional connectivity of cognitive and pain modulatory networks using brain imaging in SCD.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBehavioral symptom managementIndividual sessions focused on behavioral and cognitive strategies for managing sleep disturbance, pain, and other symptoms of sickle cell disease
OTHERSickle cell disease managementIndividual sessions focused on understanding and managing sickle cell disease

Timeline

Start date
2017-11-05
Primary completion
2023-06-30
Completion
2023-10-27
First posted
2017-05-12
Last updated
2025-01-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03150433. Inclusion in this directory is not an endorsement.

Sleep and Pain in Sickle Cell Disease (NCT03150433) · Clinical Trials Directory